5,16718,339Research and development3052411,650958General and administrative1,9902,1249,1219,646Total operating expenses6,1796,68425,93828,943Operating income 4147203,2492,158Interest and other (income) expense, net(218)66(117)135Income before income taxes6326543,3662,023Income tax expense: Current tax expense (benefit)(24)116165214Deferred tax expense (benefit)1721491,056606Total income tax expense1482651,221820Net income
$
484$
389$
2,145$
1,203Basic net income per share
$
0.09$
0.07$
0.41$
0.23Diluted net income per share
$
0.09$
0.07$
0.40$
0.22Shares used for basic net income per share5,2415,3625,2375,326Shares used for diluted net income per share5,3405,4585,3385,489
Balance Sheet DataIn Thousands (unaudited)December 31,2011December 31,2012Cash and cash equivalents
$
6,332$
5,784Total current assets28,89132,955Property and equipment, net4,8696,005Total assets61,89466,826Line of credit—2,552Total current liabilities9,28914,389Stockholders' equity48,43948,862
'/>"/>SOURCE Heska Corporation Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 Related medicine technology :1.
Heska Announces Quarterly Dividend of $0.10 Per Share2.
Heska to Present at B. Riley Investor Conference3.
Heska Corporation Announces Amendment To Its Odd-Lot Tender Offer4.
Webcast Alert: Heska Announces Third Quarter 2012 Earnings Conference Call Webcast5.
Heska Enters Distribution Agreement with MWI Veterinary Supply6.
Heska Reports Third Quarter 2012 Earnings7.
Webcast Alert: Heska Announces Fourth Quarter and Year-End 2012 Earnings Conference Call Webcast8.
Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes9.
Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 201210.
JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies11.
Misonix Announces New Distribution Agreement For Panama